An analyst for RBC Capital Markets predicted that Stryker will have more business in 2010 due to increased demand for orthopedic surgeries, according to a report by the Seattle Times.
Analyst Glenn Novarro said hospitals are budgeting for more knee and hip replacement procedures and capital spending will bounce back from the constraints of the recession.
The prediction came as Stryker announced plans to buy Ascent Healthcare Solutions, a reprocessor of single-use devices, including some of Stryker’s own devices, for $525 million.
Read the Seattle Times’ report on Stryker.
The highest-paid CEOs at spine and orthopedic medtech companies saw total compensation of more than $20 million. Here is how…
Elon Musk’s brain-implant company, Neuralink, may soon have a new competitor in the market. Neurotechnology startup Precision Neuroscience has earned…
Alphatec CEO Patrick Miles earned about $6.2 million in total compensation, according to the company’s April 11 Securities and Exchange…
Comments are closed.